Suchergebnisse - "Sookoian, Silvia"

PubPharm (289)

1

The gene expression signature of metabolic dysfunction- associated steatotic liver disease from a multiomics perspective

enthalten in: Clinical and molecular hepatology | 2024

von Pirola, C. | Sookoian, S.

CommentOn: Clin Mol Hepatol. 2024 Jan 26;:. - PMID 38281815

2

Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver disease

enthalten in: EBioMedicine | 2024

von Pirola, C. | Salatino, A. | Fernández Gianotti, T. | +3

3

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

enthalten in: Annals of hepatology | 2024

von Rinella, M. | Lazarus, J. | Ratziu, V. | +51

4

From NAFLD to MASLD : updated naming and diagnosis criteria for fatty liver disease

enthalten in: Journal of lipid research | 2024

von Rinella, M. | Sookoian, S.

5

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

enthalten in: Journal of hepatology | 2023

von Rinella, M. | Lazarus, J. | Ratziu, V. | +51

CommentIn: Eur J Intern Med. 2023 Nov;117:1-2. - PMID 37714774

6

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Rinella, M. | Lazarus, J. | Ratziu, V. | +151

7

The serum uric acid/creatinine ratio is associated with nonalcoholic fatty liver disease in the general population

enthalten in: Journal of physiology and biochemistry | 2023

von Sookoian, S. | Pirola, C.

8

Non-alcoholic fatty liver disease mediates the effect of obesity on arterial hypertension

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2023

von Pirola, C. | Sookoian, S.

9

SARS-CoV-2 targets the liver and manipulates glucose metabolism

enthalten in: Trends in molecular medicine | 2023

von Pirola, C. | Sookoian, S.

CommentOn: Proc Natl Acad Sci U S A. 2023 May 23;120(21):e2217119120. - PMID 37186819

10

An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease

enthalten in: Hepatobiliary surgery and nutrition | 2023

von Sun, D. | Targher, G. | Byrne, C. | +45

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]